Staff training and academic detailing for Tobacco Use
Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY, New York, NY
Staff training and academic detailingN/AWaitlist AvailableLed by Scott E. Sherman, MD MPHResearch Sponsored by VA Office of Research and DevelopmentEligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Must not have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up2-year intervention period
Awards & highlights
No Placebo-Only Group
Study Summary
This trial will study whether an opt-out or opt-in approach is more effective in referring smokers to treatment.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2-year intervention period
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2-year intervention period
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Abstinence at the end of the 2-year intervention period
Proportion of smokers who accept referral to treatment (Quitline or text messaging)
Proportion of smokers who engage in treatment with the Quitline or text messaging service
Secondary outcome measures
Cost-effectiveness of the two approaches (opt-out vs opt-in)
Use of smoking cessation medications
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Opt-out tobacco treatmentExperimental Treatment1 Intervention
The investigators will directly change the treatment status quo by implementing a clinical reminder that automatically initiates tobacco treatment referral at the time the reminder is activated.
Group II: Opt-in clinical reminderExperimental Treatment1 Intervention
As the investigators have done previously, the reminder will be self-explanatory, and will walk staff through each step of referral. The reminder will include the following domains: normative advice, referral to treatment, handout
Find a site
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,553 Previous Clinical Trials
2,888,830 Total Patients Enrolled
4 Trials studying Tobacco Use
3,669 Patients Enrolled for Tobacco Use
Scott E. Sherman, MD MPHPrincipal Investigator
Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY1 Previous Clinical Trials
220 Total Patients Enrolled
Steven S. Fu, MD MSCEPrincipal Investigator
Minneapolis VA Health Care System, Minneapolis, MN3 Previous Clinical Trials
10,714 Total Patients Enrolled
Media Library
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are researchers still accepting participants for this experiment?
"From the data hosted on clinicaltrials.gov, it is apparent that this study has ceased to recruit patients; with a first post date of August 28th 2019 and its last update being August 3rd 2022. Nevertheless, there are still 55 other studies actively enrolling participants as we speak."
Answered by AI
Recent research and studies